Low Hematocrit Is a Strong Predictor of Poor Prognosis in Lung Cancer Patients

Morbidity and mortality of lung cancer rank first in China and worldwide. Thus, noninvasive prognostic biomarkers are critical for clinicians to perform risk assessment in lung cancer patients prior to or during the course of treatment. In this study, we evaluated the prognostic value of preoperativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xin, Zhang, Fengmin, Qiao, Wenbo, Zhang, Xiansheng, Zhao, Zhefeng, Li, Mingqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207876/
https://www.ncbi.nlm.nih.gov/pubmed/30417013
http://dx.doi.org/10.1155/2018/6804938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207876/
https://www.ncbi.nlm.nih.gov/pubmed/30417013
http://dx.doi.org/10.1155/2018/6804938

Ejemplares similares